Pregnancy-related acute renal failure

Area of Science:

• Nephrology
• Obstetrics and Gynecology
• Critical Care Medicine

Background:

• Pregnancy-related acute renal failure (PR-ARF) represented 9% of acute renal failure (ARF) cases requiring dialysis between 1958 and 1987.
• The incidence of PR-ARF significantly decreased over three decades, both in proportion to total ARF and relative to total pregnancies.

Purpose of the Study:

• To analyze the incidence, outcomes, and associated factors of pregnancy-related acute renal failure (PR-ARF) over a 30-year period.
• To evaluate the impact of preeclampsia-eclampsia (PE-E) and abruptio placentae on maternal and renal prognosis in PR-ARF cases.

Main Methods:

• Retrospective analysis of 81 cases of PR-ARF observed from 1958 to 1987.
• Comparison of PR-ARF incidence across three successive ten-year periods.
• Evaluation of maternal mortality, irreversible renal damage, and specific complications like PE-E and abruptio placentae.

Main Results:

• Maternal mortality for PR-ARF was high at 32%, with 5 deaths in the last decade.
• Irreversible renal damage occurred in 11.6% of PR-ARF cases, rising to 26.3% in preeclampsia-eclampsia (PE-E) cases.
• PE-E complicated by abruptio placentae showed a worse maternal and renal prognosis. DIC, microangiopathic hemolytic anemia, and prostacyclin imbalance were not significantly linked to renal damage severity. Heparin therapy showed no benefit and increased hemorrhagic risks.

Conclusions:

• Pregnancy-related acute renal failure (PR-ARF) is now infrequent but remains a serious condition with significant mortality and morbidity.
• Effective prevention strategies are crucial for managing PR-ARF.
• Early identification and management of conditions like PE-E and abruptio placentae are vital for improving outcomes in PR-ARF.